Recent studies have shown that CHI3L1 is highly expressed in solid tumors, including lung cancer, breast cancer, and colorectal cancer, and is closely associated with tumor invasiveness, chemotherapy resistance, and poor prognosis (12–18). Here, CHI3L1 is linked to lung carcinoma.